Steven Cook Sells 1,607 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,607 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $25.01, for a total value of $40,191.07. Following the completion of the transaction, the chief financial officer owned 187,209 shares of the company’s stock, valued at $4,682,097.09. This represents a 0.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Omada Health Price Performance

Shares of NASDAQ:OMDA opened at $24.37 on Friday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The company has a market cap of $1.49 billion, a P/E ratio of 487.40 and a beta of 1.73. The stock’s fifty day moving average price is $20.87 and its 200-day moving average price is $16.43.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. Omada Health had a return on equity of 2.67% and a net margin of 1.39%. On average, sell-side analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a report on Friday, May 8th. BMO Capital Markets reiterated an “outperform” rating and set a $24.00 target price on shares of Omada Health in a research note on Friday, August 7th. Barclays increased their price target on Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Evercore reaffirmed an “outperform” rating and issued a $20.00 price objective on shares of Omada Health in a report on Friday, May 8th. Finally, Robert W. Baird upped their price objective on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research report on Wednesday. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and an average target price of $25.75.

Trending Headlines about Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Q2 results exceeded expectations. Omada reported adjusted earnings of $0.08 per share, compared with analysts’ expectation of a $0.02 loss, while revenue of approximately $87.8 million topped the $80.9 million consensus estimate. The results suggest growth in its digital chronic-care platform is increasingly converting into profitability. Omada Health Q2 earnings analysis
• Positive Sentiment: Several analysts raised their targets. Robert W. Baird lifted its price target from $15 to $25, while maintaining a neutral rating. Other recent targets include $27 from Citizens JMP and $35 from BTIG. The broader analyst consensus remains “Moderate Buy,” with an average target around $25.67–$25.75.
• Positive Sentiment: Institutional ownership increased. Perceptive Advisors and BlackRock reportedly initiated positions, Millennium Management expanded its stake, and Versant Capital Management increased its holdings by more than 300%. These moves may reinforce investor confidence in Omada’s growth outlook.
• Neutral Sentiment: Baird’s neutral stance highlights limited near-term upside. Its $25 target is only modestly above the recent trading level, suggesting the earnings beat and growth prospects may already be substantially reflected in the stock price.
• Negative Sentiment: Multiple senior executives sold shares. CEO Sean Duffy sold 8,628 shares, CFO Steven Cook sold 16,842 shares across two transactions, President Wei-Li Shao sold 8,866 shares, and Chief Accounting Officer Craig Gracey sold 1,042 shares. Although these sales may reflect personal liquidity or compensation planning, concentrated selling near $25 can weigh on sentiment. Omada Health insider trading report
• Negative Sentiment: Valuation risk remains elevated. Omada’s market capitalization is approximately $1.5 billion, while its reported price-to-earnings ratio is above 475. With the shares close to their 52-week high, any slowdown in revenue growth or profitability could prompt profit-taking.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OMDA. Raymond James Financial Inc. bought a new position in Omada Health in the second quarter worth approximately $32,000. Quarry LP purchased a new stake in shares of Omada Health in the 4th quarter worth $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health in the 4th quarter worth $32,000. Inlight Wealth Management LLC bought a new position in Omada Health in the 4th quarter worth $45,000. Finally, Versant Capital Management Inc lifted its position in Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.